New Xarelto Studies Show Link to Eye Hemorrhaging and Stomach Bleeding, Says

Lawsuit website reports that even more data has called Johnson & Johnson's blood thinner into question, with two new studies showing that there is an increased risk in stomach bleeding and eye hemorrhaging; this is in addition to numerous lawsuit claims with concerns for uncontrollable bleeding events that lead to long hospital stays or death.

Jul 23, 2015, 05:00 ET from MT Services LLC

NEW ORLEANS, July 23, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates, announced today that two new studies have shown a link between Xarelto and stomach bleeds and eye hemorrhaging. Johnson & Johnson's blood thinner has been linked to uncontrollable bleeding events in the past, and now, according to Drug Watch, new data has emerged that Xarelto increases the risk of stomach bleeding and eye hemorrhaging. While the two new studies are concerning, because these are two newfound side effects of the blood thinner, the main concern is still uncontrollable bleeding events that lead to death. It has yet to be determined if lawsuit claims will develop based on the new report. A similar blood thinner drug, Pradaxa, settled 4K claims involving uncontrollable bleeding events for approximately $160K per case.     

According to court documents, there are currently more than 300 lawsuits filed over Xarelto in the federal litigation in Louisiana, with an additional approximate 160 cases as of now with similar claims pending in Pennsylvania's mass tort proceeding. Lawsuits against Bayer and Johnson & Johnson's subsidiary, Janssen Pharmaceuticals, include claims of serious health problems and even death as a result of uncontrollable bleeding events. There is no known antidote at this time, according to experts. The federal multidistrict litigation (MDL) is being overseen in the U.S. District Court in the Eastern District of Louisiana (In Re: Xarelto Products Liability Litigation, No. 2592).

Chris Janish, CEO of MTS, commented on the recent studies linking Xarelto to stomach bleeds and eye hemorrhaging, "Clearly this new report comes at a tough time for J&J's Xarelto blood thinning drug as they continue to fight hundreds of uncontrollable bleeding claims, which continue to rise monthly. The litigation is expected to be a lengthy one and could be a two pronged fight for J&J if additional claims arise based on the new data."

MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific bleeding case. To learn more about MTS' services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit:

If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and/or complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit:

If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, and would like to speak with a live agent, call: 877.571.0405.

You may also fill out a quick application online at: and an agent will contact you shortly.

Disclaimer:  MT Services LLC, operator of, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page.

Chris Janish, CEO 
Ph. 877.571.0405